期刊文献+

苦参素联合甘草酸二铵治疗慢性乙型肝炎52例 被引量:2

下载PDF
导出
摘要 目的 :探讨苦参素注射液和甘草酸二铵 (甘利欣 )治疗慢性乙型肝炎的疗效。方法 :将 96例慢性乙型肝炎分为治疗组 5 2例和对照组 44例 ,治疗组用苦参素 40 0mg ,im ,qd ,同时联用甘草酸二铵 15 0mg ,tid ;对照组单用甘草酸二铵胶囊或加用一般护肝药物 ,疗程 3个月 ,治疗前后各检测肝功能 ,HBsAg、HBeAg及HBV DNA。结果 :HBeAg、HBV DNA阴转率治疗组分别为 3 8.5 % (2 0 5 2 ) ,42 .3 % (2 2 5 2 ) ,对照组两者皆为 15 .9% (7 44 ) ,差异有极显著性 (P <0 .0 1) ,治疗组ALT、AST复常率亦显著高于对照组 (P <0 .0 5 )。结论 :苦参素联合甘草酸二铵能有效抑制乙肝病毒 (HBV)复制 ,是治疗慢性乙型肝炎安全有效的药物。
作者 周建芳
出处 《医药导报》 CAS 2004年第1期36-36,共1页 Herald of Medicine
  • 相关文献

参考文献2

二级参考文献10

  • 1[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 2[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 3[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 4[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 5[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 6[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 7[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 8[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.
  • 9[9]Tsabota A. Corrbinecl ursodeoxycholic acid and glycyrrhizin therapy forchronic hepatitis C virus infection:a randomized controlled trial in 170patients[J].Eur J Gastroenterd Hepatol, 1999, 11(10):1 077.
  • 10[10]Shiota G, Harada K, Ishida M, et al. Inhibition of hepatocellularcarcinoma by glycyrrhizin in diethylnitrosa-mine-treated mice[J]. Carcinogenesis, 1999,20(1):59.

共引文献130

同被引文献5

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部